Outcomes | Study design | Anticipated absolute effectsc (95% CI) | Relative effect (95% CI) | №. of participants (studies) | Certainty of the evidence (GRADE) | |
---|---|---|---|---|---|---|
Risk with non-prone | Risk with prone | |||||
Non-intubated patients | ||||||
Mortality | RCT | 224 per 1000 | 204 per 1000 (175–238) | RR 0.91 (0.78–1.06) | 2404 (8) | ⨁⨁⨁⨁ High |
NRS | 314 per 1000 | 176 per 1000 (141–220) | RR 0.56 (0.45–0.70) | 3361 (18) | ⨁◯◯◯ Very lowa | |
Need for intubation | RCT | 389 per 1000 | 315 per 1000 (280–351) | RR 0.81 (0.72–0.90) | 2156 (7) | ⨁⨁⨁⨁ High |
NRS | 412 per 1000 | 267 per 1000 (206–350) | RR 0.65 (0.50–0.85) | 3374 (18) | ⨁◯◯◯ Very lowa | |
Adverse events | RCT | 24 per 1000 | 23 per 1000 (16–34) | RR 0.97 (0.66–1.43) | 7011 (6) | ⨁⨁⨁◯ Moderateb |
NRS | Cases in the prone group were reported as follows: desaturation or hemodynamic worsening 0/30 [34], back pain 2/30 [34] and 3/57 [42], bloating sensation 2/30 [34], gastric distension and vomit 0/81 [30], peripheral line removal 2/57 [42] and 2/81 [30], nasal skin ulceration 2/81 [30], major adverse events 0/48 [44], overall adverse events 0/17 [5] and 0/38 [46] | 716 (6) | ⨁◯◯◯ Very lowa,b | |||
Intubated patients | ||||||
Mortality | NRS | 525 per 1000 | 504 per 1000 (441–573) | RR 0.96 (0.84–1.09) | 995 (2) | ⨁◯◯◯ Very lowa |
Chen et al. [38] reported better survival in prone group than in non-prone group (adjusted hazard ratio 0.282, 95% CI 0.126 to 0.63) | 40 (1) | |||||
Adverse events | NRS | Cases in the prone group were reported as follows: endotracheal tube dislocation 0/62 [9], peripheral line removal 2/62 [9] | 261 (1) | ⨁◯◯◯ Very lowa,b |